Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States

NCT01287247 is registered in ClinicalTrials.gov with Merz North America, Inc. as lead sponsor.

NCT NCT01287247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Lead sponsor
Merz North America, Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
April 30, 2013
Enrollment
688 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

blepharospasm, cervical dystonia